Malibu Boats Inc (MBUU) Jumps 9.7% on February 04

Equities Staff |

Malibu Boats Inc (MBUU) was among the biggest gainers on the Russell 2000 for Thursday February 04 as the stock popped 9.7% to $14.02, representing a gain of $1.24 per share. Some 165,173 shares traded hands on 868 trades, compared with an average daily volume of 120,322 shares out of a total float of 17.88 million. The stock opened at $12.73 and traded with an intraday range of $14.06 to $12.38.

After today's gains, Malibu Boats Inc reached a market cap of $250.71 million. Malibu Boats Inc has had a trading range between $24.14 and $11.97 over the last year, and it had a 50-day SMA of $15.05 and a 200-day SMA of $17.46.

The stock has a P/E Ratio of 12.4.

Malibu Boats Inc is a designer, manufacturer and marketer of performance sport boats. Its boats are used for water sports, including water skiing, wakeboarding and wake surfing, as well as general recreational boating.

Malibu Boats Inc is based out of Loudon, TN and has some 509 employees. Its CEO is Jack D. Springer.

For a complete fundamental analysis analysis of Malibu Boats Inc, check out’s Stock Valuation Analysis report for MBUU. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…